Speaker: Saad Kenderian

0:30:02

CAR-T cell therapy in lymphoma

0:04:22

Current challenges in CAR-T cell therapy and the role of the tumor microenvironment

0:55:10

CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized Medicine

0:02:11

Future prospects for CAR-T cell therapy in AML

0:02:10

Targeting CAFs in the bone marrow to prevent CAR-T resistance in multiple myeloma

0:02:17

The challenges of implementing CAR-T therapy in CLL

0:02:02

Enhancing immunotherapy for CLL patients with ibrutinib

0:04:36

Highlights from the immunotherapy in CLL session

0:01:56

BTKi combinations for CLL

0:01:39

MRD in CLL: hype or hope?

0:22:31

ICTC Session 3b CAR T cells experience from Hangzhou

1:53:01

How do I sequence CLL therapy in 2024?

0:03:36

2018 Regenerative Medicine and Surgery Course

0:33:03

New CARs and Used CARs for Leukemia and Beyond

0:29:41

History of CAR Approval and Next Generation CARs - Carl June